RIGL Rigel Pharma Total Asset Value of Company
Rigel Pharmaceuticals (RIGL) is a commercial biopharmaceutical business where the primary R&D and staffing costs have already been incurred, making every new sale of low-production-cost tablets highly profitable. This price chart on GURU.Markets clearly demonstrates that total assets amount to 363.90, while the company maintains leadership in narrow hematological niches by avoiding price dumping. Stable demand for blood correction agents ensures patent-protected revenue.
Analytical breakdowns and data insights for company Rigel Pharmaceuticals Inc (RIGL)
- share price and consensus valuation forecast:
- market capitalization data:
- issuer book value statistics:
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Rigel Pharmaceuticals|RIGL - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Rigel Corp|RIGL - Company Aggregate Debts|Debts to Book Capitalization Rigel Corp|RIGL - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Rigel Pharmaceuticals
Fundamental valuation:Rigel Pharmaceuticals
To identify the fundamental leaders of the sector, it is essential for analysts to evaluate the actual scale of the business by excluding market volatility. This indicator reverse-engineers the total value of resources via ROA, allowing for a comparison of the asset base of Rigel Pharmaceuticals (RIGL) with the expansion of its drugs in oncology centers, while assessing the company's stability via the total assets chart.
Key competitors
ARGX (argenx.com) - Aggregate Company Assets|Aggregate Company Assets BioNTech|Abivax - Total Asset Value of Company|Company Total Assets ADMA|PTGX (Protagonist Corp) - Aggregate Asset Value|Company Total Assets IMVT (Immunovant, Inc.)|Company Total Assets kiniksa.com KNSA|GRFS - Aggregate Company Assets|Aggregate Asset Value ADPT (Adaptive Biotech)|Celldex (CLDX) - Aggregate Company Assets|Cumulative Company Assets Aurinia Corp|BCRX (BioCryst) - Company Total Assets|Company Total Assets veratx.com|Cumulative Company Assets DNTH (Dianthus Therapeutics, Inc.)|PHVS (Pharvaris NV) - Aggregate Asset Value|Company Total Assets ABCL (abcellera.com)|Company Total Asset Base Tourmaline (TRML)|PGEN - Aggregate Company Assets|pharming.com (PHAR) - Cumulative Company Assets|Nektar Therapeutics Inc. (NKTR) - Aggregate Company Assets|Cumulative Company Assets Upstream Bio, Inc.|Cumulative Company Assets ZBIO|Company Total Assets Immunome Bio|Aggregate Company Assets Gossamer Bio, Inc. (GOSS)|kalvista.com - Total Business Assets|Company Total Assets SEPN (Septerna)|Pieris Pharma (PVLA) - Company Assets|SVRA - Aggregate Company Assets|Aggregate Asset Value ANAB (AnaptysBio Inc.)|ATXS: Company Total Assets|ENGN - Company Total Asset Base|RAPT (RAPT Therapeutics) - Company Total Assets|JBIO - Company Balance Sheet Assets|Company Total Assets ACRS|KYTX - Company Assets|Aggregate Company Assets Tiziana Life Sciences TLSA|cabalettabio.com - Aggregate Company Assets|VTYX: Cumulative Company Assets|Aggregate Asset Value THTX (Theratechnologies, Inc.)|Avalo Therapeutics Inc. (AVTX) - Aggregate Company Assets|Total Asset Value of Company ELDN (Eledon Pharmaceuticals, Inc)|AGEN (Agenus) - Company Total Assets|CLYM: Aggregate Asset Value|Company Total Assets ZURA|Company Total Assets aTyr Pharma Inc (ATYR)|Aggregate Company Assets Adagene Inc. ADAG|Aggregate Asset Value IMA|STTK - Aggregate Company Assets|Equillium, Inc. (EQ) - Cumulative Company Assets|CNTB: Company Total Assets|Immunic (IMUX) - Company Total Assets|ATRA (Atara Biotherapeutics, Inc.) - Company Total Assets|Cumulative Company Assets InflaRx GmbH (IFRX)|Company Total Assets XFOR|ACET - Company Assets|Celularity - Cumulative Company Assets|Company Total Assets INmune Bio Inc INMB|BRNS: Cumulative Company Assets|Kezar Life Sciences Inc - Aggregate Business Assets|SABS: Company Total Assets|AKTX - Company Total Asset Base|ENLV (Enlivex Therapeutics Ltd) - Company Total Assets|Cumulative Company Assets Q32 Bio Corp (QTTB)|Company Total Assets GOVX|Company Total Assets Edesa Biotech Corp (EDSA)|Aggregate Company Assets iBio, Inc. IBIO|Carisma Therapeutics Inc - Aggregate Company Assets|XTLB - Aggregate Company Assets|Company Total Asset Base Bolt Biotherapeutics BOLT|hcwbiologics.com (HCWB) - Aggregate Company Assets|Aptevo Therapeutics Inc. - Aggregate Asset Value|AIM (AIM ImmunoTech Inc.) - Company Total Assets|Aditxt Corp (ADTX) - Company Total Asset Base|Company Total Assets GRI|XORTX Therapeutics Inc (XRTX) - Company Balance Sheet Assets|Aggregate Company Assets ReShape Lifesciences HIND|Revelation Biosciences Corp - Aggregate Company Assets|INDP - Aggregate Company Assets|Total Asset Value of Company SCNI|CALI: Company Total Assets|Affimed N.V. - Aggregate Asset Value|ALLK (Allakos Inc) - Company Total Assets|Company Total Assets HOOKIPA|Aggregate Company Assets IGM Biosciences, Inc. (IGMS)|ITOS (iteostherapeutics.com) - Aggregate Asset Value|Aggregate Company Assets Ocean Biomedical OCEA|TCBP - Cumulative Company Assets|Third Harmonic Bio, Inc - Company Total Assets